A Correlative Study of p53 Protein Alteration and p53 Gene Mutation in Glioblastoma Multiforme

Brain Pathology

Volumn 3, Issue 3, 1993, Pages 229-235

  Newcomb, Elizabeth W ^a,b   Madonia, William J ^a   Pisharody, Sobha ^a   Lang, Frederick F ^a   Koslow, Maxim ^a,b   Miller, Douglas C ^a,b  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b Department of Pathology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ARTICLE; CLINICAL ARTICLE; GENE MUTATION; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; SUPPRESSOR GENE;

ANTIBODIES, MONOCLONAL; BASE SEQUENCE; BLOTTING, SOUTHERN; BRAIN NEOPLASMS; EXONS; GENE AMPLIFICATION; GENES, P53; GLIOBLASTOMA; HUMAN; IMMUNOHISTOCHEMISTRY; MOLECULAR SEQUENCE DATA; MUTATION; POLYMORPHISM (GENETICS); PROTEIN P53; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027313366     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/j.1750-3639.1993.tb00749.x     Document Type: Article

References (33)

1. p53 mutation in human cancers
2. The p53 tumor suppressor gene
3. Localization of gene for human p53 tumour antigen to band 17p13
4. Structural aspects of the p53 protein in relation to gene evolution
5. Activating mutations for transformation by p53 produce a gene product that forms an hsc70‐p53 complex with an altered half‐life
6. Growth regulation of a cellular tumor antigen, p53, in transformed cells
7. p53 immunostaining is a marker of malignancy in diagnostic cytopathology
8. Loss of heterozygosity of p53 gene and p53 protein expression in human colorectal carcinomas
9. Expression of p53 and 17p allelic loss in colorectal carcinoma
10. Maintenance of p53 alterations throughout breast cancer progression
11. Pattern of p53 mutation in breast cancers of women of the midwestern United States
12. Overexpression and mutation of p53 in Endometrial Carcinoma
13. Overexpression and mutation of p53 in epithelial ovarian cancer
14. Loss of 17p, mutation of the p53 gene, and overexpression of p53 protein in esophageal squamous cell carcinomas
15. p53 abnormalities in different subtypes of human sarcomas
16. p53 mutations in human malignant gliomas: Comparison of loss of heterozygosity with mutation frequency
17. Isolation of human p53 specific monoclonal antibodies and their use in the studies of human p53 expression
18. Amplification of a gene encoding a p53‐associated protein in human sarcomas
19. The mdm‐2 oncogene product forms a complex with the p53 protein and inhibits p53‐mediated transactivation
20. Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers
21. A role for sunlight in skin cancer: UV‐induced p53 mutation in squamous cell carcinoma
22. Comparative study of p53 gene and protein alteration in human astrocytic tumors
23. TP53 mutations and 17p deletions in human astrocytomas
24. Scanning from an independently specified branch point defines the 3′ splice site of mammalian introns
25. p53 function and dysfunction
26. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53
27. Evidence for the involvement of a potential second tumor suppressor gene on chromosome 17 distinct from p53 in malignant astrocytomas
28. Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node‐negative breast cancer
29. Participation of p53 protein in the cellular response to DNA damage
30. ras‐induced hyperplasia occurs with mutation of p53, but activated ras and myc together can induce carcinoma without p53 mutation